Last reviewed · How we verify
concurrent chemotherapy with radiation — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
concurrent chemotherapy with radiation (concurrent chemotherapy with radiation) — Zhejiang Cancer Hospital. Concurrent chemotherapy with radiation involves administering chemotherapy and radiation therapy simultaneously to treat cancer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| concurrent chemotherapy with radiation TARGET | concurrent chemotherapy with radiation | Zhejiang Cancer Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- concurrent chemotherapy with radiation CI watch — RSS
- concurrent chemotherapy with radiation CI watch — Atom
- concurrent chemotherapy with radiation CI watch — JSON
- concurrent chemotherapy with radiation alone — RSS
Cite this brief
Drug Landscape (2026). concurrent chemotherapy with radiation — Competitive Intelligence Brief. https://druglandscape.com/ci/concurrent-chemotherapy-with-radiation. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing